drugset / Trial / NCT05065905

Study of Interferon-Gamma in the Complex Treatment of Patients Infected With HIV and Tuberculosis

NCT05065905

RandomizedParallel-groupOpen-labelTreatment

Summary

The primary purpose of this study is to assess the safety and efficacy of interferon-gamma by subcutaneous injection in complex treatment of patients with co-infection of HIV and pulmonary tuberculosis and to determine the rational of its use.

Timeline

Start
2006-01-19
Primary completion
2006-03-29
Completion
2006-04-06

Drugs

EvaluationDrugModalityDoseRoute
Subject interferon gamma Protein / enzyme biologic 500000 iu Subcutaneous